Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
301-315 of 582
Maternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
NeuroFrontiersMaternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
Eliza C. Miller, MD
Recognizing and Addressing Medical Gaslighting in Healthcare
NeuroFrontiersRecognizing and Addressing Medical Gaslighting in Healthcare
Michele Longo, MD
Self-assessment on statin eligibility without prescription using a web app
ACC Action CenterSelf-assessment on statin eligibility without prescription using a web app
Steven Nissen, MD
Promising results for APOC3 ASO in familial chylomicronemia syndrome
ACC Action CenterPromising results for APOC3 ASO in familial chylomicronemia syndrome
Erik Stroes
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
ACC Action CenterIncreasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Alexander J. Blood, MD
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
ACC Action CenterMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Daniel Gaudet, MD, PhD
- advertisement
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
ACC Action CenterAPOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
Brian Bergmark, MD
Stopping aspirin after 1 month DAPT in ACS patients after stenting
ACC Action CenterStopping aspirin after 1 month DAPT in ACS patients after stenting
Gregg Stone, MD
Head-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
ACC Action CenterHead-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
Howard C. Herrmann, MD
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
ACC Action CenterNo improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
Michael Gibson, MD
Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
ACC Action CenterEarly aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
Michael Koren, MD
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
ACC Action CenterNo effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Javed Butler, MD
- advertisement
Children Achieve Year-Long HIV Remission After Treatment Pause
Clinician's RoundtableChildren Achieve Year-Long HIV Remission After Treatment Pause
Assessing Interest in Oral vs. LAI ART Among Women with HIV
Clinician's RoundtableAssessing Interest in Oral vs. LAI ART Among Women with HIV
Research Identifies a Potential Link Between Sleep Apnea and Memory Loss
NeuroFrontiersResearch Identifies a Potential Link Between Sleep Apnea and Memory Loss
